Second-Line Combination Therapies in Pancreatic Cancer: Where Are We Now?

被引：4
|
作者：
Uccello, Mario [1 ]
Moschetta, Michele [1 ]
Arkenau, Hendrik-Tobias [1 ]
机构：
[1] Sarah Cannon Res Inst UK, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 12期
关键词：
PACLITAXEL PLUS GEMCITABINE; TRIAL;
D O I：
10.1200/JCO.2016.71.0921
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1370 / +
页数：3
相关论文
共 50 条
  • [21] Second-line combination therapies in nonsmall cell lung cancer without known driver mutations
    Bluthgen, Maria-Virginia
    Besse, Benjamin
    EUROPEAN RESPIRATORY REVIEW, 2015, 24 (138): : 582 - 593
  • [22] The use of combination monoclonal antibody therapies in lupus-where are we now?
    Rua, Joana
    Dall'Era, Maria
    Isenberg, David
    RHEUMATOLOGY, 2023, 62 (05) : 1724 - 1729
  • [23] Any Second-Line Therapy for Advanced Pancreatic Cancer?
    Li, Jia
    Merl, Man Yee
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2010, 11 (02): : 151 - 153
  • [24] Survival benefit with second-line combination in endometrial cancer
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2022, 19 (03) : 149 - 149
  • [25] Survival benefit with second-line combination in endometrial cancer
    Diana Romero
    Nature Reviews Clinical Oncology, 2022, 19 : 149 - 149
  • [26] Second-line treatment and consolidation therapies in advanced ovarian cancer
    Conte, PF
    Gadducci, A
    Cianci, C
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2001, 11 : 52 - 56
  • [27] Efficacy of combination chemotherapy with itraconazole for treating metastatic pancreatic cancer in the second-line setting.
    Inoue, Kayo
    Tsubamoto, Hiroshi
    Sonoda, Takashi
    Ikuta, Shinichi
    Tani, Satoshi
    Yamanaka, Naoki
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Apartinib in combination with S-1 for the second-line treatment of advanced pancreatic cancer (APC)
    Hang, Junjie
    Wu, Lixia
    Yin, Ruohan
    Liu, Muhan
    Xu, Kequn
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [29] Multiple Myeloma Darzalex®: Now also approved in Second-Line Combination Therapy
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (06) : 384 - 385
  • [30] Second-line pemetrexed-oxaliplatin combination for advanced pancreatic adenocarcinoma
    Mazzer, M.
    Zanon, E.
    Foltran, L.
    De Pauli, F.
    Cardellino, G.
    Iaiza, E.
    Ermacora, P.
    Aprile, G.
    Fasola, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345